{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:39:48Z","timestamp":1788475188535,"version":"build-2803163510"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ijbiomac.2020.12.058","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T10:10:13Z","timestamp":1607595013000},"page":"321-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Chitosan applications in studying and managing osteosarcoma"],"prefix":"10.1016","volume":"169","author":[{"given":"Parisa","family":"Maleki Dana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Hallajzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zatollah","family":"Asemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Mansournia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijbiomac.2020.12.058_bb0005","first-page":"519m","article-title":"Metastatic breast cancer","volume":"88","author":"Peart","year":"2017","journal-title":"Radiol. Technol."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0010","article-title":"Reduction-responsive polypeptide nanomedicines significantly inhibit progression of orthotopic osteosarcoma","volume":"23","author":"Yin","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0015","series-title":"Pediatric and Adolescent Osteosarcoma","volume":"vol. 152","author":"Jaffe","year":"2010"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1309\/UC6KQHLD9LV2KENN","article-title":"Osteosarcoma","volume":"125","author":"Klein","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","article-title":"Osteosarcoma treatment - where do we stand? A state of the art review","author":"Luetke","year":"2014","journal-title":"Cancer Treat Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.12.058_bb0030","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1245\/s10434-009-0825-6","article-title":"Differential presentations, clinical courses, and survivals of osteosarcomas of the proximal humerus over other extremity locations","volume":"17","author":"Cho","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.12.058_bb0035","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/pbc.20077","article-title":"Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity","volume":"43","author":"Kaste","year":"2004","journal-title":"Pediatr. Blood Cancer"},{"issue":"22","key":"10.1016\/j.ijbiomac.2020.12.058_bb0040","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1002\/cncr.25287","article-title":"Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study Group","volume":"116","author":"Kager","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ocl.2005.06.004","article-title":"Osteosarcoma: basic science and clinical implications","volume":"37","author":"Hayden","year":"2006","journal-title":"Orthop Clin North Am"},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.12.058_bb0050","first-page":"754","article-title":"Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs; probably a syndrome entity","volume":"88","author":"Bloom","year":"1954","journal-title":"AMA Am J Dis Child"},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.12.058_bb0055","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1302\/0301-620X.74B6.1447251","article-title":"A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families","volume":"74","author":"Porter","year":"1992","journal-title":"J Bone Joint Surg Br"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0060","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1200\/JCO.2006.08.4558","article-title":"Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome","volume":"25","author":"Hicks","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2020.12.058_bb0065","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jnci\/95.9.669","article-title":"Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome","volume":"95","author":"Wang","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0070","first-page":"47","article-title":"Hereditary retinoblastoma: host resistance and second primary tumors","volume":"65","author":"Matsunaga","year":"1980","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.12.058_bb0075","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/bjc.1986.110","article-title":"Second primary neoplasms in patients with retinoblastoma","volume":"53","author":"Draper","year":"1986","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0080","series-title":"The Multiple Function of Long Noncoding RNAs in Osteosarcoma Progression, Drug Resistance and Prognosis","author":"Xu","year":"2020"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0085","doi-asserted-by":"crossref","first-page":"627254","DOI":"10.1155\/2012\/627254","article-title":"The genetics of osteosarcoma","volume":"2012","author":"Martin","year":"2012","journal-title":"Sarcoma"},{"issue":"270","key":"10.1016\/j.ijbiomac.2020.12.058_bb0090","first-page":"271","article-title":"Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors","author":"Araki","year":"1991","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.12.058_bb0095","first-page":"809","article-title":"The retinoblastoma protein in osteoblast differentiation and osteosarcoma","volume":"6","author":"Deshpande","year":"2006","journal-title":"Curr. Mol. Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2020.12.058_bb0100","first-page":"3042","article-title":"Mutation spectrum of the retinoblastoma gene in osteosarcomas","volume":"54","author":"Wadayama","year":"1994","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.12.058_bb0105","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/00043426-200305000-00003","article-title":"Genetic and epigenetic alterations of the cell cycle regulators and tumor suppressor genes in pediatric osteosarcomas","volume":"25","author":"Pati\u00f1o-Garc\u00eda","year":"2003","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1097-4644(199610)63:1<37::AID-JCB3>3.0.CO;2-0","article-title":"Oncogene alterations in primary, recurrent, and metastatic human bone tumors","volume":"63","author":"Pompetti","year":"1996","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0115","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0959-8049(02)00747-5","article-title":"Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders","volume":"39","author":"Smeland","year":"2003","journal-title":"Eur. J. Cancer"},{"issue":"13","key":"10.1016\/j.ijbiomac.2020.12.058_bb0120","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.ejca.2009.03.005","article-title":"Prognostic factors and outcomes for osteosarcoma: an international collaboration","volume":"45","author":"Pakos","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00432-009-0690-5","article-title":"Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients","volume":"136","author":"Harting","year":"2010","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.12.058_bb0130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.mph.0000169251.57611.8e","article-title":"Height as a risk factor for osteosarcoma","volume":"27","author":"Longhi","year":"2005","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2020.12.058_bb0135","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.1995.03520320043039","article-title":"Outcome of treatment for childhood cancer in black as compared with white children. The St Jude Children\u2019s Research Hospital experience, 1962 through 1992","volume":"273","author":"Pui","year":"1995","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.12.058_bb0140","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<370::AID-IJC11>3.0.CO;2-C","article-title":"Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood","volume":"77","author":"Le Vu","year":"1998","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.12.058_bb0145","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/1097-0142(1971)28:5<1087::AID-CNCR2820280502>3.0.CO;2-F","article-title":"Radiation-induced sarcoma of bone","volume":"28","author":"Arlen","year":"1971","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40744-016-0050-2","article-title":"Osteosarcoma overview","volume":"4","author":"Lindsey","year":"2017","journal-title":"Rheumatol Ther"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<71::AID-CNCR13>3.0.CO;2-5","article-title":"ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma","volume":"77","author":"Onda","year":"1996","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.12.058_bb0160","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/cncr.10360","article-title":"ErbB2 expression is correlated with increased survival of patients with osteosarcoma","volume":"94","author":"Akatsuka","year":"2002","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.ijbiomac.2020.12.058_bb0165","doi-asserted-by":"crossref","first-page":"16517","DOI":"10.18632\/oncotarget.4140","article-title":"Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies","volume":"6","author":"Gemoll","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.058_bb0170","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3390\/ijms16022294","article-title":"FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma","volume":"16","author":"Li","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.12.058_bb0175","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1007\/s13277-015-4578-5","article-title":"miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma","volume":"37","author":"Zhou","year":"2016","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3892\/ol.2015.3907","article-title":"Expression of high mobility group box 1 protein predicts a poorer prognosis for patients with osteosarcoma","volume":"11","author":"He","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0185","series-title":"From Genomics to Metabolomics: Emerging Metastatic Biomarkers in Osteosarcoma","first-page":"719","author":"Dean","year":"2018"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1302\/2058-5241.4.180086","article-title":"Bone tumours around the elbow: a rare entity","volume":"4","author":"Savvidou","year":"2019","journal-title":"EFORT Open Rev"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-319-07323-1_4","article-title":"Osteosarcoma","volume":"162","author":"Moore","year":"2014","journal-title":"Cancer Treat. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0200","first-page":"205","article-title":"Bone cancer: diagnosis and treatment principles","volume":"98","author":"Ferguson","year":"2018","journal-title":"Am. Fam. Physician"},{"issue":"Suppl. 7","key":"10.1016\/j.ijbiomac.2020.12.058_bb0205","doi-asserted-by":"crossref","first-page":"vii320","DOI":"10.1093\/annonc\/mdq276","article-title":"Osteosarcoma","volume":"21","author":"Ritter","year":"2010","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40744-016-0050-2","article-title":"Osteosarcoma overview","volume":"4","author":"Lindsey","year":"2017","journal-title":"Rheumatology and Therapy"},{"issue":"25","key":"10.1016\/j.ijbiomac.2020.12.058_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201909938","article-title":"Cocrystal strategy toward multifunctional 3D-printing scaffolds enables NIR-activated photonic osteosarcoma hyperthermia and enhanced bone defect regeneration","volume":"30","author":"Xiang","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0220","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ctrv.2010.02.007","article-title":"Targets for cancer therapy in childhood sarcomas","author":"Wachtel","year":"2010","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0225","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biomaterials.2015.12.018","article-title":"Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: turning a bone antiresorptive agent into an anticancer therapeutic","volume":"82","author":"Au","year":"2016","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.ijbiomac.2020.12.058_bb0230","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1007\/s12274-018-2066-0","article-title":"Tumor microenvironment-responsive hyaluronate-calcium carbonate hybrid nanoparticle enables effective chemotherapy for primary and advanced osteosarcomas","volume":"11","author":"Zhang","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0235","first-page":"1","article-title":"The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade","author":"Kathawala","year":"2015","journal-title":"Churchill Livingstone"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0240","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2016.11.019","article-title":"Cancer stem cells in osteosarcoma","volume":"386","author":"Brown","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0245","series-title":"Cancer Chemotherapy: Principles and Practice","author":"Chabner","year":"1990"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0250","series-title":"Cancer: Principles and Practice of Oncology Vols 1 and 2","author":"DeVita","year":"2008"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.058_bb0255","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1470-2045(05)01734-1","article-title":"Surgical options for children with osteosarcoma","volume":"6","author":"Grimer","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0260","article-title":"Strontium\/chitosan\/hydroxyapatite\/norcantharidin composite that inhibits osteosarcoma and promotes osteogenesis in vitro","volume":"2020","author":"Z","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.12.058_bb0265","first-page":"204","article-title":"Evaluation of clinical results and complications of structural allograft reconstruction after bone tumor surgery","volume":"4","author":"Gharedaghi","year":"2016","journal-title":"Archives of Bone and Joint Surgery"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.12.058_bb0270","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","article-title":"Chitosan-based drug delivery systems","volume":"81","author":"Bernkop-Schn\u00fcrch","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.058_bb0275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijbiomac.2009.11.004","article-title":"Alginate-chitosan\/hydroxyapatite polyelectrolyte complex porous scaffolds: preparation and characterization","volume":"46","author":"Han","year":"2010","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2020.12.058_bb0280","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.3390\/md13085156","article-title":"Chitosan: an update on potential biomedical and pharmaceutical applications","volume":"13","author":"Cheung","year":"2015","journal-title":"Mar Drugs"},{"issue":"11","key":"10.1016\/j.ijbiomac.2020.12.058_bb0285","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1248\/cpb.58.1423","article-title":"Chitosan nanoparticles: a promising system in novel drug delivery","volume":"58","author":"Nagpal","year":"2010","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.12.058_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030594","article-title":"Multicomponent, tumor-homing chitosan nanoparticles for cancer imaging and therapy","volume":"18","author":"Key","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.12.058_bb0295","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2217\/17435889.3.6.845","article-title":"Nanoparticles as protein and gene carriers to mucosal surfaces","volume":"3","author":"de la Fuente","year":"2008","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0300","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijbiomac.2013.04.043","article-title":"Chitosan-based nanomaterials: a state-of-the-art review","volume":"59","author":"Shukla","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0305","first-page":"765","article-title":"Recent advances of chitosan nanoparticles as drug carriers","volume":"6","author":"Wang","year":"2011","journal-title":"Int. J. Nanomedicine"},{"issue":"9","key":"10.1016\/j.ijbiomac.2020.12.058_bb0310","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2174\/1389557519666190112142735","article-title":"Chitosan and its derivatives - biomaterials with diverse biological activity for manifold applications","volume":"19","author":"Paul","year":"2019","journal-title":"Mini Rev Med Chem"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.12.058_bb0315","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/jbm.a.10009","article-title":"Mineralization of matrix vesicles isolated from a human osteosarcoma cell line in culture with water-soluble chitosan-containing medium","volume":"66","author":"Yamada","year":"2003","journal-title":"Journal of Biomedical Materials Research - Part A"},{"issue":"10","key":"10.1016\/j.ijbiomac.2020.12.058_bb0320","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.biomaterials.2003.08.022","article-title":"Early gene expression analyzed by cDNA microarray and RT-PCR in osteoblasts cultured with water-soluble and low molecular chitooligosaccharide","volume":"25","author":"Ohara","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0325","doi-asserted-by":"crossref","DOI":"10.1177\/0960327120930266","article-title":"Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice","author":"Abo Mansour","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2019.111773","article-title":"Apoptotic induction and anti-metastatic activity of eugenol encapsulated chitosan nanopolymer on rat glioma C6 cells via alleviating the MMP signaling pathway","volume":"203","author":"Li","year":"2020","journal-title":"J. Photochem. Photobiol. B Biol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2020.12.058_bb0335","doi-asserted-by":"crossref","first-page":"10664","DOI":"10.1039\/C9NR10673A","article-title":"RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer","volume":"12","author":"Yadav","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115682","article-title":"Targeted delivery and apoptosis induction of trans-resveratrol-ferulic acid loaded chitosan coated folic acid conjugate solid lipid nanoparticles in colon cancer cells","volume":"231","author":"Senthil Kumar","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0345","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1089\/biores.2019.0028","article-title":"Antioxidant properties and redox-modulating activity of chitosan and its derivatives: biomaterials with application in cancer therapy","volume":"9","author":"Ivanova","year":"2020","journal-title":"BioResearch Open Access"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0350","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-015-0068-4","article-title":"Glycol chitosan incorporated retinoic acid chlorochalcone (RACC) nanoparticles in the treatment of osteosarcoma","volume":"14","author":"Qin","year":"2015","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0355","article-title":"Nanomedicine-based combination of gambogic acid and retinoic acid chlorochalcone for enhanced anticancer efficacy in osteosarcoma","volume":"83","author":"L","year":"2016","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.058_bb0360","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3892\/mmr.2015.4709","article-title":"Effects of RNA interference-mediated knockdown of livin and survivin using monomethoxypolyethylene glycol-chitosan nanoparticles in MG-63 osteosarcoma cells","volume":"13","author":"Guan","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0365","first-page":"439","article-title":"Anticancer properties of chitosan against osteosarcoma, breast cancer and cervical cancer cell lines","volume":"10","author":"Abedia","year":"2019","journal-title":"Caspian Journal of Internal Medicine"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110710","article-title":"Biomimetic TiO2-chitosan\/sodium alginate blended nanocomposite scaffolds for tissue engineering applications","volume":"110","author":"Kolathupalayam Shanmugam","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0375","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ijbiomac.2020.02.245","article-title":"Developing a biopolymeric chitosan supported Schiff-base and Cu(II), Ni(II) and Zn(II) complexes and biological evaluation as pro-drug","volume":"152","author":"Malekshah","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0380","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2147\/IJN.S55943","article-title":"Multifunctional materials for bone cancer treatment","volume":"9","author":"Ficai","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0385","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","article-title":"Osteosarcoma treatment\u2013where do we stand? A state of the art review","volume":"40","author":"Luetke","year":"2014","journal-title":"Cancer Treat. Rev."},{"issue":"49","key":"10.1016\/j.ijbiomac.2020.12.058_bb0390","doi-asserted-by":"crossref","first-page":"27040","DOI":"10.1021\/acsami.5b09112","article-title":"Localized co-delivery of doxorubicin, cisplatin, and methotrexate by thermosensitive hydrogels for enhanced osteosarcoma treatment","volume":"7","author":"Ma","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"27","key":"10.1016\/j.ijbiomac.2020.12.058_bb0395","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","article-title":"Osteosarcoma: current treatment and a collaborative pathway to success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0400","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2147\/IJN.S44393","article-title":"Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration","author":"Gu","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0405","series-title":"Biomaterial-based Regional Chemotherapy: Local Anticancer Drug Delivery to Enhance Chemotherapy and Minimize its Side-effects","first-page":"927","author":"Krukiewicz","year":"2016"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0410","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.msec.2017.12.024","article-title":"pH-responsive mesoporous ZSM-5 zeolites\/chitosan core-shell nanodisks loaded with doxorubicin against osteosarcoma","volume":"85","author":"Yang","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"issue":"38","key":"10.1016\/j.ijbiomac.2020.12.058_bb0415","doi-asserted-by":"crossref","first-page":"7866","DOI":"10.1039\/C7TB01830D","article-title":"Hollow mesoporous ZSM-5 zeolite\/chitosan ellipsoids loaded with doxorubicin as pH-responsive drug delivery systems against osteosarcoma","volume":"5","author":"Wen","year":"2017","journal-title":"J. Mater. Chem. B"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.12.058_bb0420","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.biomaterials.2009.09.069","article-title":"The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model","volume":"31","author":"Tan","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0425","first-page":"90","article-title":"Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma","author":"S","year":"2017","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"12","key":"10.1016\/j.ijbiomac.2020.12.058_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/nano9121652","article-title":"Doxorubicin\u00b7hydrochloride\/cisplatin-loaded hydrogel\/nanosized (2-hydroxypropyl)-beta-cyclodextrin local drug-delivery system for osteosarcoma treatment in vivo","volume":"9","author":"Yoon","year":"2019","journal-title":"Nanomaterials"},{"issue":"5","key":"10.1016\/j.ijbiomac.2020.12.058_bb0435","doi-asserted-by":"crossref","DOI":"10.1007\/s10856-020-06379-5","article-title":"Combinational delivery of anticancer drugs for osteosarcoma treatment using electrosprayed core shell nanocarriers","volume":"31","author":"Prasad","year":"2020","journal-title":"J Mater Sci Mater Med"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.12.058_bb0440","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jbm.10312","article-title":"Calcium phosphate\/chitosan composite scaffolds for controlled in vitro antibiotic drug release","volume":"62","author":"Zhang","year":"2002","journal-title":"J. Biomed. Mater. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0445","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.2042-7158.2012.01572.x","article-title":"Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model","volume":"65","author":"Tan","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2020.12.058_bb0450","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.biomaterials.2009.03.022","article-title":"A chitosan-dipotassium orthophosphate hydrogel for the delivery of doxorubicin in the treatment of osteosarcoma","volume":"30","author":"Ta","year":"2009","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0455","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/md15040096","article-title":"Multifaceted applications of chitosan in cancer drug delivery and therapy","volume":"15","author":"Babu","year":"2017","journal-title":"Marine Drugs"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0460","series-title":"Gene Therapy Clinical Trials Worldwide to 2017: An Update","author":"Ginn","year":"2018"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0465","series-title":"Viral Vectors for Gene Therapy: Methods and Protocols","author":"Manfredsson","year":"2019"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0470","series-title":"Rational Design of Gene Therapy Vectors","first-page":"246","author":"Pan","year":"2019"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.12.058_bb0475","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/diseases6030057","article-title":"Nonviral gene therapy for cancer: a review","volume":"6","author":"Hidai","year":"2018","journal-title":"Diseases"},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.12.058_bb0480","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/md17060381","article-title":"Recent advances in chitosan-based carriers for gene delivery","volume":"17","author":"Cao","year":"2019","journal-title":"Marine Drugs"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0485","series-title":"Chitosan Nanoparticles for siRNA Delivery In Vitro","first-page":"143","author":"Ragelle","year":"2016"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0490","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3390\/polym10040444","article-title":"Chitosan in non-viral gene delivery: role of structure, characterization methods, and insights in cancer and rare diseases therapies","volume":"10","author":"Santos-Carballal","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0495","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2147\/IJN.S147747","article-title":"Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy","volume":"13","author":"Wang","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0500","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.msec.2019.02.047","article-title":"Graphene oxide functionalized with chitosan based nanoparticles as a carrier of siRNA in regulating Bcl-2 expression on Saos-2 & MG-63 cancer cells and its inflammatory response on bone marrow derived cells from mice","volume":"99","author":"Saravanabhavan","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"issue":"9","key":"10.1016\/j.ijbiomac.2020.12.058_bb0505","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/jbm.a.35414","article-title":"Spontaneous gene transfection of human bone cells using 3D mineralized alginate-chitosan macrocapsules","volume":"103","author":"Green","year":"2015","journal-title":"Journal of Biomedical Materials Research - Part A"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0510","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2006.01.044","article-title":"Pre-deliver chitosanase to cells: a novel strategy to improve gene expression by endocellular degradation-induced vector unpacking","volume":"314","author":"Liang","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0515","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-015-0278-7","article-title":"Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review","volume":"35","author":"Belkacemi","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.ijbiomac.2020.12.058_bb0520","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1016\/j.biomaterials.2007.03.016","article-title":"Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma","volume":"28","author":"Dass","year":"2007","journal-title":"Biomaterials"},{"issue":"27","key":"10.1016\/j.ijbiomac.2020.12.058_bb0525","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1016\/j.biomaterials.2009.05.035","article-title":"A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy","volume":"30","author":"Ta","year":"2009","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.12.058_bb0530","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/02652040802033673","article-title":"Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity","volume":"25","author":"Dass","year":"2008","journal-title":"J. Microencapsul."},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.12.058_bb0535","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/1535-7163.MCT-08-0086","article-title":"c-Jun knockdown sensitizes osteosarcoma to doxorubicin","volume":"7","author":"Dass","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0540","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addr.2019.04.003","article-title":"Tissue engineered models of healthy and malignant human bone marrow","volume":"140","author":"Chramiec","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0545","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.actbio.2019.08.020","article-title":"Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression","volume":"99","author":"Gonzalez Diaz","year":"2019","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.058_bb0550","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1021\/acsbiomaterials.7b00097","article-title":"3d tissue engineered in vitro models of cancer in bone","volume":"4","author":"Sitarski","year":"2018","journal-title":"ACS Biomater Sci Eng"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0555","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1021\/bm701268s","article-title":"The effect of chitosan on the in vitro biological performance of chitosan-poly(butylene succinate) blends","volume":"9","author":"Coutinho","year":"2008","journal-title":"Biomacromolecules"},{"issue":"10","key":"10.1016\/j.ijbiomac.2020.12.058_bb0560","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1902\/jop.2005.76.10.1778","article-title":"Biological evaluation of chitosan nanofiber membrane for guided bone regeneration","volume":"76","author":"Shin","year":"2005","journal-title":"J. Periodontol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2020.12.058_bb0565","article-title":"Preparation and characterization of RGD-immobilized chitosan scaffolds","volume":"26","author":"Mh","year":"2005","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0570","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijbiomac.2009.03.011","article-title":"Wet chemical synthesis of chitosan hydrogel-hydroxyapatite composite membranes for tissue engineering applications","volume":"45","author":"Madhumathi","year":"2009","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0575","article-title":"Enhanced differentiation of osteoblastic cells on novel chitosan\/\u03b2-1,3-glucan\/bioceramic scaffolds for bone tissue regeneration","volume":"10","author":"A","year":"2015","journal-title":"Biomedical Materials"},{"issue":"2","key":"10.1016\/j.ijbiomac.2020.12.058_bb0580","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/107632703764664800","article-title":"Calcium phosphate-chitosan composite scaffolds for bone tissue engineering","volume":"9","author":"Zhang","year":"2003","journal-title":"Tissue Eng."},{"issue":"Pt A","key":"10.1016\/j.ijbiomac.2020.12.058_bb0585","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ijbiomac.2018.06.175","article-title":"In vivo study on scaffolds based on chitosan, collagen, and hyaluronic acid with hydroxyapatite","volume":"118","author":"Kaczmarek","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"PartA","key":"10.1016\/j.ijbiomac.2020.12.058_bb0590","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijbiomac.2017.08.173","article-title":"New composite materials prepared by calcium phosphate precipitation in chitosan\/collagen\/hyaluronic acid sponge cross-linked by EDC\/NHS","volume":"107","author":"Kaczmarek","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"PartA","key":"10.1016\/j.ijbiomac.2020.12.058_bb0595","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ijbiomac.2017.09.017","article-title":"The application of chitosan\/collagen\/hyaluronic acid sponge cross-linked by dialdehyde starch addition as a matrix for calcium phosphate in situ precipitation","volume":"107","author":"Kaczmarek","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0600","article-title":"Characterization of gelatin and chitosan scaffolds cross-linked by addition of dialdehyde starch","volume":"13","author":"B","year":"2017","journal-title":"Biomedical Materials (Bristol, England)"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110606","article-title":"Thermo-reversible injectable hydrogel composing of pluronic F127 and carboxymethyl hexanoyl chitosan for cell-encapsulation","volume":"185","author":"Yap","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"11","key":"10.1016\/j.ijbiomac.2020.12.058_bb0610","doi-asserted-by":"crossref","first-page":"14620","DOI":"10.1021\/acsomega.8b02090","article-title":"Cisplatin-loaded graphene oxide\/chitosan\/hydroxyapatite composite as a promising tool for osteosarcoma-affected bone regeneration","volume":"3","author":"Sumathra","year":"2018","journal-title":"ACS Omega"},{"issue":"6","key":"10.1016\/j.ijbiomac.2020.12.058_bb0615","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.actbio.2006.05.011","article-title":"Human osteosarcoma cell adhesion behaviour on hydroxyapatite integrated chitosan-poly(acrylic acid) polyelectrolyte complex","volume":"2","author":"Sailaja","year":"2006","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0620","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1080\/10717544.2018.1507058","article-title":"A local drug delivery system based on visible light-cured glycol chitosan and doxorubicin\u00b7hydrochloride for thyroid cancer treatment in vitro and in vivo","volume":"25","author":"Yoo","year":"2018","journal-title":"Drug Deliv"},{"issue":"sup2","key":"10.1016\/j.ijbiomac.2020.12.058_bb0625","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/21691401.2018.1470529","article-title":"Injectable visible light-cured glycol chitosan hydrogels with controlled release of anticancer drugs for local cancer therapy in vivo: a feasible study","volume":"46","author":"Hyun","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0630","doi-asserted-by":"crossref","DOI":"10.3390\/md17010041","article-title":"Photo-cured glycol chitosan hydrogel for ovarian cancer drug delivery","volume":"17","author":"Hyun","year":"2019","journal-title":"Mar Drugs"},{"issue":"1","key":"10.1016\/j.ijbiomac.2020.12.058_bb0635","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijfoodmicro.2010.09.012","article-title":"Antimicrobial properties of chitosan and mode of action: a state of the art review","volume":"144","author":"Kong","year":"2010","journal-title":"Int. J. Food Microbiol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034711","article-title":"Chitosan-graft-branched polyethylenimine copolymers: influence of degree of grafting on transfection behavior","volume":"7","author":"Pezzoli","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0645","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijbiomac.2013.11.020","article-title":"Bioactivity and biocompatibility of a chitosan-tobermorite composite membrane for guided tissue regeneration","volume":"64","author":"Hurt","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2020.12.058_bb0650","doi-asserted-by":"crossref","first-page":"14620","DOI":"10.1021\/acsomega.8b02090","article-title":"Cisplatin-loaded graphene oxide\/chitosan\/hydroxyapatite composite as a promising tool for osteosarcoma-affected bone regeneration","volume":"3","author":"Sumathra","year":"2018","journal-title":"ACS Omega"},{"issue":"23","key":"10.1016\/j.ijbiomac.2020.12.058_bb0655","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1039\/C5TB00175G","article-title":"Hybrid nanostructured hydroxyapatite\u2013chitosan composite scaffold: bioinspired fabrication, mechanical properties and biological properties","volume":"3","author":"Guo","year":"2015","journal-title":"J. Mater. Chem. B"},{"issue":"19","key":"10.1016\/j.ijbiomac.2020.12.058_bb0660","doi-asserted-by":"crossref","first-page":"16435","DOI":"10.1021\/acsami.7b03532","article-title":"Hydroxyapatite nanowire@magnesium silicate core-shell hierarchical nanocomposite: synthesis and application in bone regeneration","volume":"9","author":"Sun","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"7","key":"10.1016\/j.ijbiomac.2020.12.058_bb0665","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/jbm.b.32760","article-title":"Bioactivity and mechanical properties of collagen composite membranes reinforced by chitosan and \u03b2-tricalcium phosphate","volume":"100","author":"Lee","year":"2012","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.ijbiomac.2020.12.058_bb0670","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.msec.2016.03.060","article-title":"Fabrication and characterization of novel nano-biocomposite scaffold of chitosan-gelatin-alginate-hydroxyapatite for bone tissue engineering","volume":"64","author":"Sharma","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0675","doi-asserted-by":"crossref","DOI":"10.1116\/1.4944661","article-title":"Role of p H-responsiveness in the design of chitosan-based cancer nanotherapeutics: a review","volume":"11","author":"Suarato","year":"2016","journal-title":"Biointerphases"},{"issue":"3","key":"10.1016\/j.ijbiomac.2020.12.058_bb0680","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/jbm.a.10009","article-title":"Mineralization of matrix vesicles isolated from a human osteosarcoma cell line in culture with water-soluble chitosan-containing medium","volume":"66","author":"Yamada","year":"2003","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"4","key":"10.1016\/j.ijbiomac.2020.12.058_bb0685","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1039\/c6tx00039h","article-title":"Cytotoxicity investigation of luminescent nanohybrids based on chitosan and carboxymethyl chitosan conjugated with Bi(2)S(3) quantum dots for biomedical applications","volume":"5","author":"Carvalho","year":"2016","journal-title":"Toxicol Res (Camb)"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020352168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813020352168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:29:47Z","timestamp":1758875387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813020352168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":137,"alternative-id":["S0141813020352168"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.058","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chitosan applications in studying and managing osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}